Haemonetics (HAE) Tops Q4 EPS by 7c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.40 +0.74%
EPS Growth %: +1.6%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +1.6%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q4 EPS of $0.77, $0.07 better than the analyst estimate of $0.70. Revenue for the quarter came in at $304 million versus the consensus estimate of $290.79 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi upgrades Haemonetics to Buy, raises price target to $123
- Redburn upgrades Southwest, stays bullish on Delta and United
- Element Solutions (ESI) PT Lowered to $47 at UBS, Buy Rating Maintained
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
